Cancer Gene Therapy

Papers
(The H4-Index of Cancer Gene Therapy is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Reducing the risks of nuclear war—the role of health professionals158
Platelet activation: a barrier to effective antitumor immunity153
ADAM12 expression is upregulated in cancer cells upon radiation and constitutes a prognostic factor in rectal cancer patients following radiotherapy149
Characteristics and developmental trajectory of clinical trials focused on tumor-infiltrating lymphocytes for cancer treatment139
P38 kinase in gastrointestinal cancers88
Application of CAR-T therapy in solid tumors: current opportunities and challenges84
Defining treatment-resistant brain cancer: Genetic screening to identify oncogene-driven immunomodulation and therapy resistance74
Use of CRISPR-based screens to identify mechanisms of chemotherapy resistance71
VPS37A loss creates CASP8-dependent vulnerability via the MAP3K7–NF-κB–CFLAR axis70
Lysine-40 succinylation of TAGLN2 induces glioma angiogenesis and tumor growth through regulating TMSB4X58
Small extracellular vesicle TGF-β in cancer progression and immune evasion53
Ending nuclear weapons, before they end us50
Role of non-coding RNAs in neuroblastoma48
Pan-cancer oncogenic properties and therapeutic potential of SF3B443
Long noncoding RNA EPCART regulates translation through PI3K/AKT/mTOR pathway and PDCD4 in prostate cancer41
Targeting TLK2 inhibits the progression of gastric cancer by reprogramming amino acid metabolism through the mTOR/ASNS axis39
TNFRSF19 promotes endoplasmic reticulum stress-induced paraptosis via the activation of the MAPK pathway in triple-negative breast cancer cells39
Self-replicating messenger RNA based cancer immunotherapy39
CircPKN2 promotes ferroptosis in bladder cancer by promoting the ubiquitination of Stearoyl-CoA Desaturase 139
Unveiling the role of the extracellular matrix in the osteosarcoma tumor microenvironment through integrated transcriptomics and experimental validation38
PDPN contributes to constructing immunosuppressive microenvironment in IDH wildtype glioma36
Viral vectors and extracellular vesicles: innate delivery systems utilized in CRISPR/Cas-mediated cancer therapy34
NRAV promotes HCC stemness via the m6A-regulated let-7c-5p/LIN28B axis33
BCL-xL dependency in chromophobe renal cell carcinoma32
Single-cell atlas reveals the immunosuppressive microenvironment and Treg cells landscapes in recurrent Glioblastoma32
WTAP stabilized by USP7 contributes to enzalutamide resistance in prostate cancer via mediating AKT m6A-modification31
Real-world outcomes of Adjuvant De Gramont versus Xelox chemotherapy in reSected gasTric cancER: a propensity score-matched analysis (ASTER study)31
Bacillus Calmette-Guerin induces CD8+ T cell infiltration and suppresses tumor progression in microsatellite stable colorectal cancer by downregulating ARID1A30
Exploring RNA biology in pseudomyxoma peritonei uncovers splicing dysregulation as a novel, targetable molecular vulnerability30
Correction to: Lycium barbarum glycopeptide targets PER2 to inhibit lipogenesis in glioblastoma by downregulating SREBP1c30
0.12501311302185